Merck Financial Statements From 2010 to 2024

MRK Stock   137.85  0.25  0.18%   
Merck KGaA financial statements provide useful quarterly and yearly information to potential Merck KGaA investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Merck KGaA financial statements helps investors assess Merck KGaA's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Merck KGaA's valuation are summarized below:
Merck KGaA does not presently have any fundamental ratios for analysis.
Check Merck KGaA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck KGaA's main balance sheet or income statement drivers, such as , as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck KGaA Valuation or Volatility modules.
  
This module can also supplement various Merck KGaA Technical models . Check out the analysis of Merck KGaA Correlation against competitors.

Merck KGaA Company Return On Asset Analysis

Merck KGaA's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Merck KGaA Return On Asset

    
  0.0656  
Most of Merck KGaA's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Merck KGaA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Merck KGaA has a Return On Asset of 0.0656. This is 100.75% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-Specialty & Generic industry. The return on asset for all Germany stocks is 146.86% lower than that of the firm.

Merck KGaA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Merck KGaA's current stock value. Our valuation model uses many indicators to compare Merck KGaA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Merck KGaA competition to find correlations between indicators driving Merck KGaA's intrinsic value. More Info.
Merck KGaA is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers reporting about  0.46  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Merck KGaA is roughly  2.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Merck KGaA's earnings, one of the primary drivers of an investment's value.

About Merck KGaA Financial Statements

Merck KGaA shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Merck KGaA investors may analyze each financial statement separately, they are all interrelated. The changes in Merck KGaA's assets and liabilities, for example, are also reflected in the revenues and expenses on on Merck KGaA's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Merck Stock Analysis

When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.